Capricor Therapeutics (CAPR) FCF Margin Growth (5y) (2016 - 2024)
Powered by 
Analysis
Capricor Therapeutics (CAPR) FCF Margin Growth (5y) (2016 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Capricor Therapeutics | 543.30 Mn | 543.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 66,674.00 |
| Sep 30, 2024 | 64,718.00 |
| Jun 30, 2024 | 12,220.00 |
| Mar 31, 2024 | 67,870.00 |
| Dec 31, 2023 | 47,896.00 |
| Sep 30, 2023 | 127,991.00 |
| Jun 30, 2023 | 66,999.00 |
| Mar 31, 2023 | 103,022.00 |
| Dec 31, 2022 | -23,075.00 |
| Sep 30, 2022 | 63,112.00 |
| Jun 30, 2021 | -193,518.00 |
| Mar 31, 2021 | -789,958.00 |
| Dec 31, 2020 | -681,779.00 |
| Sep 30, 2020 | -1.83 Mn |
| Jun 30, 2020 | -411,265.00 |
| Mar 31, 2020 | -53,970.00 |
| Dec 31, 2019 | -64,946.00 |
| Sep 30, 2019 | -98,931.00 |
| Jun 30, 2019 | 14,667.00 |
| Mar 31, 2019 | -177,748.00 |